Freenome Holdings Inc (Freenome) develops and provides a medical artificial intelligence (AI) platform which to detect cancer at its earliest stages. The company provides cell-free (cf) biomarkers which include cfDNA, Provides insights into immune response and tumor heterogeneity, cfRNA, Records which genes were actively expressed at the time of apoptosis, and Proteins, Identifies proteins associated with specific tumor types. Freenome is utilizing an AI genomics platform and developing noninvasive blood tests to detect early-stage cancer and improve precision oncology treatments. The company collaborated with pharmaceutical companies, integrated health systems and academic institutions to use its AI genomics platform for improving cancer treatment. Freenome is headquartered in South San Francisco, California, the US.
Headquarters
United States of America
Address
5th Floor, 259 East Grand Avenue, South San Francisco, California, 94080
Website
www.freenome.com
Industry
Medical Equipment
Freenome Inc premium industry data and analytics
Products and Services
| Products | Services | Brands |
|---|---|---|
| Technology Platform: | Multiomics Platform Services | Freenome |
| Multiomics Platform | Early Cancer Detection Blood Tests |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2023 | Contracts/Agreements | In January, the company entered into an agreement with Geisinger to support the sanderson study. |
| 2019 | Contracts/Agreements | In August, Freenome signed a biomarker development collaboration with ADC Therapeutics to utilize Freenome’s platform to identify patients who are most likely to respond to treatment with ADCT-402 (loncastuximab tesirine). |
| 2018 | Corporate Changes/Expansions | In June, the company and the Medical University of Graz established a new Christian Doppler Laboratory for advancing research into early-cancer detection and precision oncology options for patients. |
Competitor Comparison
| Key Parameters | Freenome Inc | Exosome Diagnostics Inc | Genomic Health Inc | Genomic Expression Inc |
|---|---|---|---|---|
| Headquarters | United States of America | United States of America | United States of America | United States of America |
| City | South San Francisco | Waltham | Redwood City | New York City |
| State/Province | California | Massachusetts | California | New York |
| No. of Employees | - | - | - | - |
| Entity Type | Private | Private | Private | Private |
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Mike Nolan | Chief Executive Officer | Senior Management | - | - |
| Julie Tran | Chief People Officer | Senior Management | - | - |
| Lance Baldo | Chief Medical Officer | Senior Management | - | - |
| Jimmy Lin | Chief Scientific Officer | Senior Management | - | - |
| Charles Roberts | Co-Founder; Chief Growth Officer | Senior Management | - | - |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer